Press Releases Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 05:00:02 24/01/2026 HKT			5-day change	1st Jan Change
83.66 ^USD	-0.92%		-0.82%	-1.87%

01-22	Leerink Partners Adjusts Edwards Lifesciences Price Target to $88 From $87, Maintains Market Perform Rating	MT
01-22	Venus Medtech Clarifies U.S. Patent Lawsuit Involving Subsidiary	MT

Press Releases

01-12	Edwards Comments on JenaValve Acquisition	AQ
01-10	Edwards Comments on JenaValve Acquisition	BU
12-27	Federal Circuit Affirms Implicit Redefinition Of Claim Terms	AQ
12-25	HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	PR
12-23	FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy	BU
12-18	Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference	BU
12-12	Edwards Lifesciences : Statement of Changes in Beneficial Ownership (Form 4)	PU
12-11	Is Writing Your Own Dictionary Dangerous? Yes.	AQ
12-06	Edwards Lifesciences : EW 2025 IC FINAL	PU
12-05	Edwards Lifesciences : 2025 Investor Conference	PU
12-04	Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference	BU
12-01	HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	PR
11-20	Defining Claim Terms By Implication: Lexicography Lessons From Aortic Innovations LLC v. Edwards Lifesciences Corporation	AQ
11-10	Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease	BU
31/10/25	Edwards Lifesciences Announces CFO Transition Plan	BU
31/10/25	Edwards Lifesciences Reports Third Quarter Results	BU
28/10/25	Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights	BU
28/10/25	Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025	BU
28/10/25	Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025	BU
23/10/25	Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025	BU
23/10/25	Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW	PR
17/10/25	EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW	BU
12/10/25	Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW	PR
07/10/25	Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW	PR
01/10/25	Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 pm